Evidence map›Paper›PMID 28572128›Full record

ArticleThe European respiratory journal2017

Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.

Marieke J van der Werf, Csaba Ködmön, Mike Catchpole

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The European respiratory journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  4. Tuberculosis elimination: where are we now?European respiratory review : an official journal of the European Respiratory Society · 2018
    Review
  5. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Marieke J van der WerfEuropean Centre for Disease Prevention and Control, Stockholm, Sweden Marieke.vanderWerf@ecdc.europa.eu.
Csaba KödmönEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Mike CatchpoleEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsTuberculosis, Multidrug-ResistantEuropeHumansMycobacterium tuberculosisAntitubercular Agents

Identifiers

PMID28572128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.